Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Radiotherapy | Research

Total marrow lymphoid irradiation IMRT treatment using a novel CT-linac

Authors: Dazhen Jiang, Di Deng, Yu Xiong, Dajiang Wang, Jian Gong, Hongli Zhao, Zhirong Bao, Yongchang Wei, Conghua Xie, Lecheng Jia, Can Liao, Shuo Liu, Hui Liu, Xiaoyong Wang

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

A novel CT-linac (kilovolt fan-beam CT-linac) has been introduced into total marrow and lymphoid irradiation (TMLI) treatment. Its integrated kilovolt fan-beam CT (kV FBCT) can be used not only for image guidance (IGRT) but also to re-calculate the dose.

Purpose

This study reported our clinical routine on performing TMIL treatment on the CT-linac, as well as dose distribution comparison between planned and re-calculated based on IGRT FBCT image sets.

Methods

11 sets of data from 5 male and 6 female patients who had underwent the TMLI treatment with uRT-linac 506c were selected for this study. The planning target volumes consist of all skeletal bones exclusion of the mandible and lymphatic sanctuary sites. A planned dose of 10 Gy was prescribed to all skeletal bones exclusion of the mandible in two fractions and 12 Gy in two fractions was prescribed to lymphatic sanctuary sites. Each TMLI plan contained two sub-plans, one dynamic IMRT for the upper body and the other VMAT for the lower extremity. Two attempts were made to obtain homogeneous dose in the overlapping region, i.e., applying two plans with different isocenters for the treatment of two fractions, and using a dose gradient matching scheme. The CT scans, including planning CT and IGRT FBCT, were stitched to a whole body CT scan for dose distribution evaluation.

Results

The average beam-on time of Planupper is 30.6 min, ranging from 24.9 to 37.5 min, and the average beam-on time of Planlower is 6.3 min, ranging from 5.7 to 8.2 min. For the planned dose distribution, the 94.79% of the PTVbone is covered by the prescription dose of 10 Gy (V10), and the 94.68% of the PTVlymph is covered by the prescription dose of 12 Gy (V12). For the re-calculated dose distribution, the 92.17% of the PTVbone is covered by the prescription dose of 10 Gy (V10), and the 90.07% of the PTVlymph is covered by the prescription dose of 12 Gy (V12). The results showed that there is a significant difference (p < 0.05) between planning V10, V12 and delivery V10, V12. There is no significant difference (p > 0.05) between planned dose and re-calculated dose on selected organs, except for right lens (p < 0.05, Dmax). The actual delivered maximum dose of right lens is apparently larger than the planned dose of it.

Conclusion

TMLI treatment can be performed on the CT-linac with clinical acceptable quality and high efficiency. Evaluation of the recalculated dose on IGRT FBCT suggests the treatment was delivered with adequate target coverage.
Literature
1.
go back to reference Han C, Schultheisss TE, Wong JYC. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation. Radiother Oncol. 2012;102(2):315–20.CrossRefPubMed Han C, Schultheisss TE, Wong JYC. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation. Radiother Oncol. 2012;102(2):315–20.CrossRefPubMed
2.
go back to reference Cherpak AJ, Monajemi T, Chytyk-Praznik K, et al. Energy-dependent OAR sparing and dose conformity for total marrow irradiation of obese patients. J Appl Clin Med Phys. 2018;19(5):532–8.CrossRefPubMedPubMedCentral Cherpak AJ, Monajemi T, Chytyk-Praznik K, et al. Energy-dependent OAR sparing and dose conformity for total marrow irradiation of obese patients. J Appl Clin Med Phys. 2018;19(5):532–8.CrossRefPubMedPubMedCentral
4.
go back to reference Colton L, Hemal S, Daniel H, Dongyun Y, Claire H, Chunhui H, An L, Guido M, Joseph R, Susanta H, Amandeep S, Haris A, Ryotaro N, Anthony S, Monzr AM, Wong Jeffrey YC, Savita D. Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia. Front Oncol. 2022;12:1017355. https://doi.org/10.3389/fonc.2022.1017355.CrossRef Colton L, Hemal S, Daniel H, Dongyun Y, Claire H, Chunhui H, An L, Guido M, Joseph R, Susanta H, Amandeep S, Haris A, Ryotaro N, Anthony S, Monzr AM, Wong Jeffrey YC, Savita D. Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia. Front Oncol. 2022;12:1017355. https://​doi.​org/​10.​3389/​fonc.​2022.​1017355.CrossRef
7.
go back to reference Daria K, Larisa S, Anna L, Francheska K, Diana T, Michael M, Rimma K, Mariya I, Dina B, Natalya M, Alexey N. Optimized conformal total body irradiation among recipients of TCRαβ/CD19-depleted grafts in pediatric patients with hematologic malignancies: single-center experience. Front Oncol. 2021;11:785916. https://doi.org/10.3389/fonc.2021.785916.CrossRef Daria K, Larisa S, Anna L, Francheska K, Diana T, Michael M, Rimma K, Mariya I, Dina B, Natalya M, Alexey N. Optimized conformal total body irradiation among recipients of TCRαβ/CD19-depleted grafts in pediatric patients with hematologic malignancies: single-center experience. Front Oncol. 2021;11:785916. https://​doi.​org/​10.​3389/​fonc.​2021.​785916.CrossRef
8.
go back to reference Aydogan B, Yeginer M, Kavak GO, et al. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Rad Oncol* Biol* Phy. 2011;81(2):592–9.CrossRef Aydogan B, Yeginer M, Kavak GO, et al. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Rad Oncol* Biol* Phy. 2011;81(2):592–9.CrossRef
9.
go back to reference Bao Z, Zhao H, Wang D, et al. Feasibility of a novel dose fractionation strategy in TMI/TMLI. Radiat Oncol. 2018;13(1):1–10.CrossRef Bao Z, Zhao H, Wang D, et al. Feasibility of a novel dose fractionation strategy in TMI/TMLI. Radiat Oncol. 2018;13(1):1–10.CrossRef
10.
go back to reference Hui SK, Verneris MR, Higgins P, et al. Helical tomotherapy targeting total bone marrow–first clinical experience at the University of Minnesota. Acta Oncol. 2007;46(2):250–5.CrossRefPubMed Hui SK, Verneris MR, Higgins P, et al. Helical tomotherapy targeting total bone marrow–first clinical experience at the University of Minnesota. Acta Oncol. 2007;46(2):250–5.CrossRefPubMed
11.
go back to reference Wong JYC, Rosenthal J, Liu A, et al. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Rad Oncol Biol Phy. 2009;73(1):273–9.CrossRef Wong JYC, Rosenthal J, Liu A, et al. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Rad Oncol Biol Phy. 2009;73(1):273–9.CrossRef
12.
go back to reference Stein A, Palmer J, Tsai NC, et al. Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed/refractory acute leukemia. Biol Blood Marrow Transplant. 2017;23(4):618–24.CrossRefPubMedPubMedCentral Stein A, Palmer J, Tsai NC, et al. Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed/refractory acute leukemia. Biol Blood Marrow Transplant. 2017;23(4):618–24.CrossRefPubMedPubMedCentral
13.
go back to reference Shueng PW, Lin SC, Chong NS, et al. Total marrow irradiation with helical tomotherapy for bone marrow transplantation of multiple myeloma: first experience in Asia. Technol Cancer Res Treat. 2009;8(1):29–37.CrossRefPubMed Shueng PW, Lin SC, Chong NS, et al. Total marrow irradiation with helical tomotherapy for bone marrow transplantation of multiple myeloma: first experience in Asia. Technol Cancer Res Treat. 2009;8(1):29–37.CrossRefPubMed
14.
go back to reference Jensen LG, Stiller T, Wong JYC, et al. Total marrow lymphoid irradiation/fludarabine/melphalan conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2018;24(2):301–7.CrossRefPubMed Jensen LG, Stiller T, Wong JYC, et al. Total marrow lymphoid irradiation/fludarabine/melphalan conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2018;24(2):301–7.CrossRefPubMed
15.
go back to reference Wong, Jeffrey YC , and Hui SK. Total Marrow Irradiation A Comprehensive Review: A Comprehensive Review. 2020. Wong, Jeffrey YC , and Hui SK. Total Marrow Irradiation A Comprehensive Review: A Comprehensive Review. 2020.
16.
go back to reference Corvò R, Zeverino M, Vagge S, et al. Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant. Radiother Oncol. 2011;98(3):382–6.CrossRefPubMed Corvò R, Zeverino M, Vagge S, et al. Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant. Radiother Oncol. 2011;98(3):382–6.CrossRefPubMed
17.
go back to reference Chultheiss TE, Wong J, Liu A, Olivera G, Somlo G. Image-guided total marrow and total lymphatic irradiation using helical tomotherapy. Int J Radiation Oncol Biol Phys 2007;67(4):1259–67. Chultheiss TE, Wong J, Liu A, Olivera G, Somlo G. Image-guided total marrow and total lymphatic irradiation using helical tomotherapy. Int J Radiation Oncol Biol Phys 2007;67(4):1259–67.
18.
go back to reference Hui SK, Verneris MR, Higgins P, et al. Helical tomotherapy targeting total bone marrow – First clinical experience at the University of Minnesota. Acta Oncol 2007;46(2):250–5. Hui SK, Verneris MR, Higgins P, et al. Helical tomotherapy targeting total bone marrow – First clinical experience at the University of Minnesota. Acta Oncol 2007;46(2):250–5.
19.
go back to reference Wong JYC, Rosenthal J, Liu An, Schultheiss T, Forman S, Somlo G. Image-Guided Total-Marrow Irradiation Using Helical Tomotherapy in Patients With Multiple Myeloma and Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Int J Radiation Oncol*Biol*Phys 2009;73(1):273–9. Wong JYC, Rosenthal J, Liu An, Schultheiss T, Forman S, Somlo G. Image-Guided Total-Marrow Irradiation Using Helical Tomotherapy in Patients With Multiple Myeloma and Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Int J Radiation Oncol*Biol*Phys 2009;73(1):273–9.
22.
go back to reference Fogliata A, Cozzi L, Clivio A, et al. Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation. Int J Radiat Oncol Biol Phys, 2011;80(2):628–36. Fogliata A, Cozzi L, Clivio A, et al. Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation. Int J Radiat Oncol Biol Phys, 2011;80(2):628–36.
23.
go back to reference Wong JYC, Rosenthal J, Liu A, Schultheiss T, Forman S, Somlo G. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys, 2009;73(1):273–9. https://doi.org/10.1016/j.ijrobp.2008.04.071 Wong JYC, Rosenthal J, Liu A, Schultheiss T, Forman S, Somlo G. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys, 2009;73(1):273–9. https://​doi.​org/​10.​1016/​j.​ijrobp.​2008.​04.​071
25.
go back to reference Wong JYC, and Hui SK. Total Marrow Irradiation A Comprehensive Review: A Comprehensive Review. 2020. Wong JYC, and Hui SK. Total Marrow Irradiation A Comprehensive Review: A Comprehensive Review. 2020.
Metadata
Title
Total marrow lymphoid irradiation IMRT treatment using a novel CT-linac
Authors
Dazhen Jiang
Di Deng
Yu Xiong
Dajiang Wang
Jian Gong
Hongli Zhao
Zhirong Bao
Yongchang Wei
Conghua Xie
Lecheng Jia
Can Liao
Shuo Liu
Hui Liu
Xiaoyong Wang
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Radiotherapy
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01380-4

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue